Drew M. Pardoll, M.D., Ph.D.

Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University Medicine

Cancer Immunology

EDUCATION

BA – Johns Hopkins University

MD – Johns Hopkins University School of Medicine

PhD – Johns Hopkins University School of Medicine

AWARDS AND ACCOLADES

Cancer Research Institute Investigators Award

Medical Student Basic Science Teaching Award

National Academy of Inventors

COMPANIES AND BOARDS

Co-Founder: Amplimmune (acquired by MedImmune/AstraZeneca), Jounce (NAS:JNCE), Potenza (Acquired by Astellas), Tizona, Ervaxx, DNAtrix

Scientific Advisory Board: WindMil, Five Prime (NASDAQ:FPRX), DNAtrix, Dracen Pharmaceuticals, Aduro (NASDAQ:ADRO) Pharmaceuticals

MEMBER OF Investment Committee

Associated Portfolio Companies

WindMIL Therapeutics
ManaT Bio